Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Zengying Liu"'
Autor:
Chen Guan, Chenyu Li, Xuefei Shen, Chengyu Yang, Zengying Liu, Ningxin Zhang, Lingyu Xu, Long Zhao, Bin Zhou, Xiaofei Man, Congjuan Luo, Hong Luan, Lin Che, Yanfei Wang, Yan Xu
Publikováno v:
European Journal of Medical Research, Vol 28, Iss 1, Pp 1-13 (2023)
Abstract Introduction Hexarelin exhibits significant protection against organ injury in models of ischemia/reperfusion (I/R)-induced injury (IRI). Nevertheless, the impact of Hexarelin on acute kidney injury (AKI) and its underlying mechanism remains
Externí odkaz:
https://doaj.org/article/e4570de7ab9b48df91d81708eacfe6a5
Autor:
Chen Guan, Chenyu Li, Lingyu Xu, Lin Che, Yanfei Wang, Chengyu Yang, Ningxin Zhang, Zengying Liu, Long Zhao, Bin Zhou, Xiaofei Man, Hong Luan, Yan Xu
Publikováno v:
European Journal of Medical Research, Vol 28, Iss 1, Pp 1-12 (2023)
Abstract Purpose Furosemide, a frequently prescribed diuretic for managing congestive heart failure and edema, remains a topic of debate regarding its potential risk of inducing acute kidney injury (AKI) in patients. Consequently, this study aims to
Externí odkaz:
https://doaj.org/article/f96e1323d92c469e8ea587e3999ef3d7
Autor:
Ningxin Zhang, Chen Guan, Zengying Liu, Chenyu Li, Chengyu Yang, Lingyu Xu, Meng Niu, Long Zhao, Bin Zhou, Lin Che, Yanfei Wang, Yan Xu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Renal ischemia reperfusion injury (IRI) is a leading and common cause of acute kidney injury (AKI), and inflammation is a critical factor in ischemic AKI progression. Calycosin (CAL), a major active component of Radix astragali, has been reported to
Externí odkaz:
https://doaj.org/article/c805ab9e2231440d8c004bee9c08eb1b
Autor:
Zengying Liu, Chen Guan, Chenyu Li, Ningxin Zhang, Chengyu Yang, Lingyu Xu, Bin Zhou, Long Zhao, Hong Luan, Xiaofei Man, Yan Xu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Acute kidney injury (AKI) is a common syndrome impacting about 13.3 million patients per year. Tilianin has been reported to alleviate myocardial ischemia/reperfusion (I/R) injury, while its effect on AKI is unknown; thus, this study aime
Externí odkaz:
https://doaj.org/article/bfacc72a22d74491b1fa9ae2162898f4
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/44b5cb8fc3674d1ea1465e607c73f6f6
Autor:
Qin Xu, Zhiyuan Zhang, Wantao Chen, Jingshuang Yu, Zengying Liu, Furong Xie, Jianbo Shi, Xin Bao
PCR/real-time PCR primer sequences and RNAi sequences used in the present study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::603236ed4ae9863b01eec30dc4d226c4
https://doi.org/10.1158/0008-5472.22421016
https://doi.org/10.1158/0008-5472.22421016
Autor:
Qin Xu, Zhiyuan Zhang, Wantao Chen, Jingshuang Yu, Zengying Liu, Furong Xie, Jianbo Shi, Xin Bao
Schematic representation of the role for ADAM10-p75NTR ICD-TRAF6-NF-kB axis in promoting anoikis resistance and metastasis identified in the present study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e5d19a068315c327db389cff82c978d
https://doi.org/10.1158/0008-5472.22421019.v1
https://doi.org/10.1158/0008-5472.22421019.v1
Autor:
Qin Xu, Zhiyuan Zhang, Wantao Chen, Jingshuang Yu, Zengying Liu, Furong Xie, Jianbo Shi, Xin Bao
Resistance to anoikis allows cancer cells to survive during systemic circulation; however, the mechanism underlying anoikis resistance remains unclear. Here we show that A disintegrin and metalloprotease 10 (ADAM10)–mediated cleavage of p75 neurotr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8be8685fc2e07d19ab0f6294955a65d2
https://doi.org/10.1158/0008-5472.c.6510816.v1
https://doi.org/10.1158/0008-5472.c.6510816.v1
Autor:
Zengying, Liu, Chen, Guan, Chenyu, Li, Ningxin, Zhang, Chengyu, Yang, Lingyu, Xu, Bin, Zhou, Long, Zhao, Hong, Luan, Xiaofei, Man, Yan, Xu
Publikováno v:
Frontiers in pharmacology. 13
Publikováno v:
Cancer Science
Tumor necrosis factor receptor-associated factor 6 (TRAF6) has been found to be involved in carcinogenesis in multiple cancers. However, the precise role of TRAF6 in cancer has not been extensively investigated and remains largely unknown. In this st